TY - JOUR
T1 - Instructive role of the microenvironment in preventing renal fibrosis
AU - Matsumoto, Kei
AU - Xavier, Sandhya
AU - Chen, Jun
AU - Kida, Yujiro
AU - Lipphardt, Mark
AU - Ikeda, Reina
AU - Gevertz, Annie
AU - Caviris, Mario
AU - Hatzopoulos, Antonis K.
AU - Kalajzic, Ivo
AU - Dutton, James
AU - Ratliff, Brian B.
AU - Zhao, Hong
AU - Darzynkiewicz, Zbygniew
AU - Rose-John, Stefan
AU - Goligorsky, Michael S.
N1 - Publisher Copyright:
© 2017 The Authors.
PY - 2017/3
Y1 - 2017/3
N2 - Accumulation of myofibroblasts is a hallmark of renal fibrosis. A significant proportion ofmyofibroblasts has been reported to originate via endothelial-mesenchymal transition. We initially hypothesized that exposingmyofibroblasts to the extractof endothelial progenitor cells (EPCs) could reverse this transition. Indeed, in vitro treatment of transforming growth factor-β1 (TGF-β1)-activated fibroblastswith EPC extract prevented expressionofα-smooth muscleactin(α-SMA);however, itdidnotenhanceexpressionof endothelial markers. In two distinctmodels of renal fibrosis—unilateral ureteral obstruction and chronic phase of folic acid-induced nephropathy—subcapsular injection of EPC extract to the kidney prevented and reversed accumulation of α-SMA-positivemyofibroblasts and reduced fibrosis. Screening the composition of EPC extract for cytokines revealed that it is enriched in leukemia inhibitory factor (LIF) and vascular endothelial growth factor. Only LIF was capable of reducing fibroblast-to-myofibroblast transition of TGF-β1-activated fibroblasts. In vivo subcapsular administration of LIF reduced the number of myofibroblasts and improved the density of peritubular capillaries; however, it did not reduce the degree of fibrosis. A receptor-independent ligand for the gp130/STAT3 pathway, hyperinterleukin- 6 (hyper-IL-6), not only induced a robust downstream increase in pluripotency factors Nanog and c-Myc but also exhibited a powerful antifibrotic effect. In conclusion, EPC extract prevented and reversed fibroblast-to-myofibroblast transition and renal fibrosis. The component of EPC extract, LIF, was capable of preventing development of the contractile phenotype of activated fibroblasts but did not eliminate TGF-β1-induced collagen synthesis in cultured fibroblasts and models of renal fibrosis,whereas a receptor-independent gp130/STAT3 agonist, hyper-IL-6, prevented fibrosis. In summary, these studies, through the evolution from EPC extract to LIF and then to hyper-IL-6, demonstrate the instructive role ofmicroenvironmental cues andmay provide in the future a facile strategy to prevent and reverse renal fibrosis.
AB - Accumulation of myofibroblasts is a hallmark of renal fibrosis. A significant proportion ofmyofibroblasts has been reported to originate via endothelial-mesenchymal transition. We initially hypothesized that exposingmyofibroblasts to the extractof endothelial progenitor cells (EPCs) could reverse this transition. Indeed, in vitro treatment of transforming growth factor-β1 (TGF-β1)-activated fibroblastswith EPC extract prevented expressionofα-smooth muscleactin(α-SMA);however, itdidnotenhanceexpressionof endothelial markers. In two distinctmodels of renal fibrosis—unilateral ureteral obstruction and chronic phase of folic acid-induced nephropathy—subcapsular injection of EPC extract to the kidney prevented and reversed accumulation of α-SMA-positivemyofibroblasts and reduced fibrosis. Screening the composition of EPC extract for cytokines revealed that it is enriched in leukemia inhibitory factor (LIF) and vascular endothelial growth factor. Only LIF was capable of reducing fibroblast-to-myofibroblast transition of TGF-β1-activated fibroblasts. In vivo subcapsular administration of LIF reduced the number of myofibroblasts and improved the density of peritubular capillaries; however, it did not reduce the degree of fibrosis. A receptor-independent ligand for the gp130/STAT3 pathway, hyperinterleukin- 6 (hyper-IL-6), not only induced a robust downstream increase in pluripotency factors Nanog and c-Myc but also exhibited a powerful antifibrotic effect. In conclusion, EPC extract prevented and reversed fibroblast-to-myofibroblast transition and renal fibrosis. The component of EPC extract, LIF, was capable of preventing development of the contractile phenotype of activated fibroblasts but did not eliminate TGF-β1-induced collagen synthesis in cultured fibroblasts and models of renal fibrosis,whereas a receptor-independent gp130/STAT3 agonist, hyper-IL-6, prevented fibrosis. In summary, these studies, through the evolution from EPC extract to LIF and then to hyper-IL-6, demonstrate the instructive role ofmicroenvironmental cues andmay provide in the future a facile strategy to prevent and reverse renal fibrosis.
KW - Green fluorescent protein
KW - Hyper-interleukin-6
KW - Leukemia inhibitory factor
KW - Transforming growth factor-β1
KW - α-Smooth muscle actin
UR - http://www.scopus.com/inward/record.url?scp=85017534875&partnerID=8YFLogxK
U2 - 10.5966/sctm.2016-0095
DO - 10.5966/sctm.2016-0095
M3 - Article
C2 - 28297566
AN - SCOPUS:85017534875
SN - 2157-6564
VL - 6
SP - 992
EP - 1005
JO - Stem Cells Translational Medicine
JF - Stem Cells Translational Medicine
IS - 3
ER -